Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

88%

7 of 8 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

Phase 2

4(57.1%)

Phase 3

2(28.6%)

N/A

1(14.3%)

7Total

Phase 2(4)

Phase 3(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01827046Phase 3Completed

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Role: collaborator

NCT00784134Phase 3Completed

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Role: collaborator

NCT02081001Phase 2Completed

PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients

Role: collaborator

NCT02081014Phase 2Completed

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

Role: collaborator

NCT00795184Not ApplicableCompleted

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy

Role: collaborator

NCT01972152Phase 2Completed

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

Role: collaborator

NCT00224770Phase 2Completed

Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

Role: collaborator

NCT00779688Completed

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Role: collaborator

All 8 trials loaded